Multiple DNA repair mechanisms and alkylator resistance in the human meduiloblastoma cell line D-283 Med (4-HCR)

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 1, 1999, Pages 73-79

  Dong, Qing ^a   Johnson, Stewart P ^a   Colvin, O Michael ^a   Bullock, Nancy ^a   Kilborn, Cindy ^a   Runyon, Gregory ^a   Sullivan, Daniel M ^b   Easton, Julia ^a   Bigner, Darell D ^a   Nahta, Rita ^a   Marks, Jeffrey ^a   Modrich, Paul ^a   Friedman, Henry S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Antineoplastic agents, alkylating; DNA repair; Drug resistance, neoplasm; Medulloblastoma; Tumor cells, cultured

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; CARMUSTINE; MELPHALAN;

ARTICLE; CROSS RESISTANCE; DNA CROSS LINKING; DNA REPAIR; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEDULLOBLASTOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ANTINEOPLASTIC AGENTS, ALKYLATING; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARMUSTINE; CEREBELLAR NEOPLASMS; DNA REPAIR; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDONUCLEASES; HUMANS; INDICATOR DILUTION TECHNIQUES; MEDULLOBLASTOMA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BIOSYNTHESIS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032942911     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050865     Document Type: Article

References (43)

1. 1. BAebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R, Howell SB (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56: 3087
2. 2. Ahmad S, Okine L, Le B, Najarian P, Vistica DT (1987) Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells. J Biol Chem 262: 15048
3. 3. Allen JC, Helson L (1981) High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55: 749
4. 4. Andersson BS, Sadeghi T, Siciliano MJ, Legerski R, Murray D (1996) Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharamacol 38: 406
5. 5. Austin CA, Marsh KL, Wasserman RA, Willmore E, Sayer PJ, Wang JC, Fisher LM (1995) Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase IIβ. J Biol Chem 270: 15739
6. 6. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) (1997) Current protocols in molecular biology. John Wiley and Sons, New York
7. 7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248
8. 8. Bramson J, Prévost J, Malapetsa A, Noe AJ, Poirier GG, Des Noyers S, Alaoui-Jamali M, Panasci L (1993) Poly(ADP-ribose) polymersase can bind melphalan damaged DNA. Cancer Res 53: 5370
9. - human cells. Cancer Res 52: 5257
10. 10. Chomczynski PN, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156
11. 11. Cleaver JE, Morgan WF (1991) Poly(ADP-ribose) polymerase: a perplexing participant in cellular responses to DNA breakage. Mutat Res 257: 1
12. 6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J Biol Chem 269: 17228
13. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylatins agents. Proc Natl Acad Sci USA 87: 5368
14. 14. Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS (1996) Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand cross-linking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines. Cancer Chemother Pharmacol 37: 242
15. 15. Drummond JT, Anthoney A, Brown R, Modrich P (1996) Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line. J Biol Chem 271: 1964
16. 16. Feldhoff PW, Mirski SEL, Cole SPC, Sullivan DM (1994) Altered suhcellular distribution of topoisomerase IIα in a drug-resistant human small cell lung cancer cell line. Cancer Res 54: 756
17. 17. Frei E III, Cucchi CA, Rosowsky A, Tantravahi R, Bernal S, Ervin TJ, Ruprecht RM, Haseltine WA (1985) Alkylating agent resistance: in vitro studies with human cell lines. Proc Natl Acad Sci USA 82: 2158
18. 18. Friedman HS, Colvin OM, Skapek SX, Ludeman SM, Elion GB, Schold SC Jr, Jacobsen PF, Muhlbaier LH, Bigner DD (1988) Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 48: 4189
19. 19. Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD (1991) Medulloblastoma: tumor biological and clinical perspectives. J Neurooncol 11: 1
20. 20. Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW (1992) Cyclophosphamide resistance in medulloblastoma. Cancer Res 52: 5373
21. 6-benzylguanine in the treatment of central nervous system tumor xenografts. Cancer Res 55: 2853
22. 22. Friedman HS, Johnson SP, Dong Q, Schold SC, Rasheed BKA, Bigner SH, Ali-Osman F, Dolan E, Colvin OM, Houghton P, German G, Drummond JT, Keir S Marcelli S, Bigner DD, Modrich P (1997) Methylator resistance mediated by mismatch repair deficiency in a glioblastomu multiforme xenograft. Cancer Res 57: 2933
23. 6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res 19: 6163
24. 24. Hilton J (1984) Deoxyribonucleic acid cross-linking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells. Biochem Pharmacol 33: 1867
25. 25. Hilton J (1984) Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res 44: 5156
26. 26. Holmes J Jr, Clark S, Modrich P (1990) Strand-specific mismatch correction in. nuclear extracts of human and Drosophila melanogaster cell lines. Proc Natl Acad Sci USA 87: 5837
27. b gene promoter in murine macrophages. Cell Immunol 166: 207
28. 28. Kat A, Thilly WG, Fang WH, Longley MJ, Li GM, Modrich P (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA 90: 6424
29. 29. Li GM, Modrich P (1995) Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci USA 92: 1950
30. 30. McGown AT, Fox BW (1986) A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 17: 223
31. 31. Murren JR, Anderson S, Fedele J, Pizzorno G, Belliveau D, Zelterman D, Burtness BA, Tocino I, Flynn SD, Beidler D, Cheng YC (1997) Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer. J Clin Oncol 15: 148
32. 32. Naegeli H (1994) Roadblocks and detours during DNA replication: mechanisms of mutagenesis in mammalian cells. Bioessays 16: 557
33. 33. Parsons R, Li GM, Longley MJ, Fang W-H, Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B, Modrich P (1993) Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227
34. 6-methylguanine-DNA methyltransferase gene. Cancer Commun 3: 241
35. 35. Pieper RO, Patel S, Ting SA, Futscher BW, Costello JF (1996) Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J Biol Chem 271: 13916
36. 6-methylguanine-DNA methyltransferase gene. Cancer Res 57: 3672
37. 37. Schabel FM Jr, Trader MW, Laster WR Jr, Wheeler GP, Witt MH (1978) Patterns of resistance and therapeutic synergism among alkylating agents. Antibiot Chemother 23: 200
38. - cells. Carcinogenesis 16: 1857
39. 39. Subramanian D, Rosenstein BS, Muller MT (1998) Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: Possible relationship with DNA repair. Cancer Res 58: 976
40. 6-methylguanine-DNA methyltransferase associated with resistance to alkylating drugs in a mammalian cell line. J Biol Chem 272: 13250
41. 41. Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E III (1986) Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res 46: 4379
42. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 17: 5612
43. 43. Waxman DJ (1990) Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy. Cancer Res 50: 6449